. Author manuscript; available in PMC: 2014 Jun 12.

Published in final edited form as: J Gastrointest Surg. 2008 Jul 19;12(12):2171–2176. doi: 10.1007/s11605-008-0584-x

Table 1.

MiR-21 Expression by In Situ Hybridization

miR-21 expression	PCA (N=80)	CP (N=45)	NP (N=12)
0 (negative)	17 (21%)	33 (73%)	11 (92%)
1+ (weak positive)	49 (61%)	12 (27%)	1 (8%)
2+ (strong positive)	14 (18%)	0 (0%)	0 (0%)
All positive	63/80 (79%)	12/45 (27%)^*	1/12 (8%)^*

p<0.0001 vs. pancreatic cancer